Loading
BRADENTON — Blake Medical Center was chosen as one of 20 hospitals in the U.S. for a global clinical trial for beating heart, mitral valve repair.
According to a press release, the RECHORD trial investigates a new device that allows cardiovascular surgeons to replace damaged tendons through a small incision while the heart is beating. The RECHORD trial compares outcomes from the procedure to traditional open-heart mitral valve surgery.
“In this trial, we can offer patients in our community that are suffering from degenerative mitral valve regurgitation, an opportunity to help us evaluate a new minimally invasive mitral valve repair technology on a beating heart that may change the way we treat patients in the near future,” says cardiothoracic surgeon Dr. Alessandro Golino in a statement.
The RECHORD trial will be led by Director of Cardiothoracic Surgery Dr. Alessandro Golino, Dr. Gino Sedillo and Dr. Ashok Krishnamurthy at Blake Medical Center.
“Blake is committed to providing exceptional and advanced heart care services to our community. We are pleased that we have been selected to participate in the RECHORD trial and with the opportunity to partner with leading cardiac centers around the world in this exciting investigation,” says Blake Medical Center CEO Dan Friedrich in the statement.
Blake Medical Center is a 383-bed, acute-care, full-service hospital in west Bradenton.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
